Game changing skin science from the 25th World Congress of Dermatology

By Julia Wray | Published: 10-Jul-2023

From period skin to microneedle serum, we round-up newness from the world of dermatology

You need to be a subscriber to read this article.
Click here to find out more.

The 25th World Congress of Dermatology took place in Singapore from 3-8 July at the Suntec Singapore Convention & Exhibition Centre. 

Taking place once every four years and bringing together the world’s leading dermatologists, scientists and researchers, the event is a calendar hotspot for brands and experts presenting the latest in skin research.

Cosmetics Business has rounded-up key findings presented by the world’s biggest beauty players last week. 

1. Pigmentary disorders affect half of women globally

Game changing skin science from the 25th World Congress of Dermatology
Research from L’Oréal’s La Roche-Posay found 50% of women globally suffer from self-reported pigmentary disorders (PD).

These include vitiligo, post-inflammatory hyperpigmentation and melasma.

In the largest study of its kind, La Roche-Posay surveyed 48,000 people across 34 countries. 

Nearly a third (28%) reported a strong impact on quality of life as a result of their PD and 44% of those with a PD reported hiding the visible part of their affected skin.

At the congress, L’Oréal presented Mexoryl 400, the patented ingredient in UVMune 400 by La Roche-Posay. 

It is said to be L’Oréal’s first technology to protect skin against ultra-long UVA and prevent skin damage caused by photoageing, photo pollution, as well as the modification of genes that can lead to skin cancer.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.

Subscribe now Already a subscriber? Sign in here.

You may also like